Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor ...
DPA International on MSN20h
Growth brings higher profits at Germany's MerckDriven by growth across the board, including in its semiconductor business, German science and technology company Merck ...
The German life-science and chemicals company attributed earnings growth to a recovery of its life-science segment, cost discipline and lower spending on research and development following the ...
Merck reported third-quarter earnings growth above expectations, helped by lower spending and a positive performance in ...
Merck, which previously predicted 2024 sales between 20.7 ... compared with 5.9 billion reported for 2023. Its Life Science ...
Historically an active player in the M&A space, Radnor-based Avantor has not found itself so busy in that realm during the ...
On Oct. 15, Modifi Bio, a Yale-based biotech company, closed an acquisition deal with Merck, an American pharmaceutical ...
Caris Life Sciences has obtained an FDA approval for its MI Cancer ... Finally, the assay can be used with Merck’s Keytruda ...
While at Merck, George led the merger integration of Merck and Schering ... modalities typically considered ‘unstructured’, rather than requiring a new tool set for each one. Our life sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback